Prognostic Impact of CD163+ Macrophages in Tumor Stroma and CD8+ T-Cells in Cancer Cell Nests in Invasive Extrahepatic Bile Duct Cancer
- PMID: 28011489
- DOI: 10.21873/anticanres.11304
Prognostic Impact of CD163+ Macrophages in Tumor Stroma and CD8+ T-Cells in Cancer Cell Nests in Invasive Extrahepatic Bile Duct Cancer
Abstract
Aim: The aim of this study was to examine the clinicopathological influence of tumor-infiltrating cluster of differentiation (CD) 163+ macrophages and CD8+ T-cells, and to clarify the prognostic effects of these cells in patients with invasive extrahepatic bile duct cancer (EHBC).
Materials and methods: The numbers of CD8+ T-cells in cancer cell nests and CD163+ macrophages in tumor stroma were evaluated using immunohistochemistry in 101 resected EHBC specimens. Correlations with clinicopathological variables and overall survival were analyzed.
Results: Perihilar EHBC and perineural invasion were significantly associated with a low number of tumor-infiltrating CD8+ T-cells. Poorly- differentiated histology and nodal metastasis were significantly associated with a high number of tumor-infiltrating CD163+ macrophages. A combination of high number of CD8+ T-cells and low number of CD163+ macrophages was independently related to better overall survival in the whole patient cohort (hazard ratio=0.127, p<0.001) and in patients treated with adjuvant chemotherapy (hazard ratio=0.139, p=0.021).
Conclusion: Infiltrating CD163+ macrophages in tumor stroma and CD8+ T-cells in cancer cell nests have a prognostic impact in patients with EHBC following resection and also after adjuvant chemotherapy.
Keywords: CD163; CD8; Extrahepatic bile duct cancer; tumor-associated macrophages; tumor-infiltrating lymphocytes.
Copyright© 2017 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.
Similar articles
-
Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.Cancer. 2008 Sep 15;113(6):1387-95. doi: 10.1002/cncr.23712. Cancer. 2008. PMID: 18671239
-
High ratio of programmed cell death protein 1 (PD-1)(+)/CD8(+) tumor-infiltrating lymphocytes identifies a poor prognostic subset of extrahepatic bile duct cancer undergoing surgery plus adjuvant chemoradiotherapy.Radiother Oncol. 2015 Oct;117(1):165-70. doi: 10.1016/j.radonc.2015.07.003. Epub 2015 Jul 30. Radiother Oncol. 2015. PMID: 26235847
-
Prognostic value of intratumoral CD8+ T lymphocyte in extrahepatic bile duct carcinoma as essential immune response.J Surg Oncol. 2003 Dec;84(4):224-8. doi: 10.1002/jso.10321. J Surg Oncol. 2003. PMID: 14756433
-
Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer.J Immunother Cancer. 2017 Apr 18;5:39. doi: 10.1186/s40425-017-0240-7. eCollection 2017. J Immunother Cancer. 2017. PMID: 28428887 Free PMC article.
-
Well-Differentiated Neuroendocrine Tumour of the Extrahepatic Bile Duct: a Case Report with Review of Literature.J Gastrointest Cancer. 2016 Mar;47(1):93-9. doi: 10.1007/s12029-015-9726-z. J Gastrointest Cancer. 2016. PMID: 25935586 Review. No abstract available.
Cited by
-
Tumor microenvironment in triple-negative breast cancer: the correlation of tumor-associated macrophages and tumor-infiltrating lymphocytes.Clin Transl Oncol. 2021 Dec;23(12):2513-2525. doi: 10.1007/s12094-021-02652-3. Epub 2021 Jun 5. Clin Transl Oncol. 2021. PMID: 34089486 Free PMC article.
-
The Immune-Genomics of Cholangiocarcinoma: A Biological Footprint to Develop Novel Immunotherapies.Cancers (Basel). 2025 Jan 15;17(2):272. doi: 10.3390/cancers17020272. Cancers (Basel). 2025. PMID: 39858054 Free PMC article. Review.
-
Tumor-infiltrating lymphocytes and macrophages as a significant prognostic factor in biliary tract cancer.PLoS One. 2023 Jan 24;18(1):e0280348. doi: 10.1371/journal.pone.0280348. eCollection 2023. PLoS One. 2023. PMID: 36693070 Free PMC article.
-
Survival benefit and biomarker of PD-1 inhibitor combination therapy in first-line of advanced biliary tract cancer: A retrospective study.Cancer Med. 2023 Nov;12(22):20699-20711. doi: 10.1002/cam4.6628. Epub 2023 Nov 6. Cancer Med. 2023. PMID: 37930138 Free PMC article.
-
A Perspective on Cell Therapy and Cancer Vaccine in Biliary Tract Cancers (BTCs).Cancers (Basel). 2020 Nov 17;12(11):3404. doi: 10.3390/cancers12113404. Cancers (Basel). 2020. PMID: 33212880 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials